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Abstract The cross-signaling between (cell) adhesion
molecules is nowadays a well-accepted phenomenon
and includes orchestrated cellular changes and changes
in the microenvironment. For example, Ep-CAM is an
epithelial adhesion molecule that prevails in active
proliferating tissue and is suppressed in a more dif-
ferentiated state of the cell. E-cadherin adhesion
complexes are typical for the advanced and terminal
differentiated cell status. During normal proliferation,
E-cadherin is not suppressed. We have demonstrated
the effect of overexpression of Ep-CAM on E-cad-
herin, which probably affects the connection of
cadherins and F-actin. Phosphatidylinositol 3-kinase
(Pi3K) participates in various regulating mechanisms,
for example in signaling to nuclei, vesicle transport,
and cytoskeletal rearrangements. The effect of
Ep-CAM on E-cadherin mediated junctions as well as
the involvement of Pi3K in regulating adherens junc-
tions, led us to investigate the potential interaction
between Pi3K and Ep-CAM. Introduction of Ep-CAM
in the epithelial cells caused abrogation of N-cadherin
mediated cell–cell adhesion, which could be inhibited
by Pi3K inhibitor LY294002. Moreover, the Pi3K
subunit p85 was precipitated with Ep-CAM from cell
lysates, and this complex showed kinase activity. The
Pi3K activity shuttled from N-cadherin to Ep-CAM.-
From our results, we conclude that Ep-CAM cross
signaling with N-cadherin involves Pi3K, resulting in
the abrogation of the cadherin adhesion complexes in
epithelial cells.
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Introduction
The maintenance of tissue integrity is a complex and
dynamic process, requiring a balance between a variety
of signaling pathways. Responding to external signals
requires many secondary pathways within the cells in
order to respond accurately and in a coordinated
fashion [1]. Disturbances in these pathways could lead
to dramatic dysfunctioning of the cell, for example
carcinogenesis. Diagnosis of early pathological devel-
opment is very difficult. First, insight and understand-
ing of the disturbed regulating pathways is required.
Ep-CAM is an adhesion molecule that is expressed
in all simple, pseudostratified epithelia, but not in
mature squamous epithelia. It is strongly associated
with cellular proliferation in vitro as well as in vivo [2].
Tumors originating from epithelial cells over-express
or express de novo Ep-CAM. De novo expression is
already detected in the precursors of carcinomas of
squamous epithelium, where Ep-CAM expression
serves as an early marker [2, 3].
Phosphatidylinositol 3 kinase (Pi3K) is an ubiqui-
tous enzyme involved in many intracellular signal
transduction pathways. It participates in various regu-
lating mechanisms, for example in cytoplasmic- to
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nuclear signaling, vesicle transport, cytoskeletal
rearrangements and CD28-B7 outside–inside signaling
[1, 4, 5]. Important target molecules are the small Rho
GTPases, which are involved in cytoskeletal organiza-
tion. Cytoskeleton (re-) arrangement results in signal-
ing to integrins and cadherins. Ras/GTP, activated by
growth factors, promotes Pi3K activity and thereby
inhibits apoptosis [6]. The Pi3K protein consists of an
85 kDa and a 110-kDa subunit. The p85 subunit is
recognized as being the regulatory subunit, while the
p110 subunit employs the actual kinase activity that
converts plasma membrane lipid PIP2 into PIP3.
E-cadherin adhesion complexes are typical for the
advanced and terminal differentiated cell status. The
Ep-CAM expression in epithelia inversely correlates
with cadherin-mediated junction complexes. In vitro
studies demonstrated that cadherin-mediated adhesions
are abrogated upon Ep-CAM introduction, probably by
affecting the connection between cadherin adhesion
complexes and F-actin [7, 8]. This results in reversing the
E-cadherin-induced epithelial phenotype of L-cells into
a mesenchymal phenotype [2, 7]. Our in vivo studies
revealed a regulated expression of Ep-CAM in pancre-
atic islet ontogeny [9]. During maturation of the pan-
creatic islet-like cells, Ep-CAM expression decreases
and simultaneously the (endocrine) differentiation in-
creases. Pi3K was demonstrated to negatively regulate
the differentiation in human fetal pancreatic cells [10].
In cells expressing cadherins, cytoskeletal rearrange-
ments are observed upon Ep-CAM introduction [8].
These rearrangements may be the result of involvement
of small GTPases or Pi3K.
The results described here, show that signaling
between Ep-CAM and cadherins involves activation of
Pi3K.
Material and methods
Cells, constructs and cell culture
Human breast epithelial cells HBL100 (clone HCA,
kindly provided by Dr. Hilkens, The Netherlands
Cancer Institute, Amsterdam. The Netherlands) were
transiently transfected with full length human Ep-CAM
cDNA that was subcloned into the pMep4 vector
(Invitrogen BV., Leek, the Netherlands), using the
HindIII/Bgl restriction sites [7]. The construct is placed
under the control of the methallothionin promotor,
which can be induced by divalent heavy metal ions
(e.g., Cd2+or Zn2+). This allows a stepwise expression of
Ep-CAM. Transfection was performed with FugeneTM6
Transfection Reagent (Boehringer Mannheim,
Mannheim, Germany) and selected by 1 mg/ml Hy-
gromycin B (Boehringer Mannheim), as described
earlier [7].
For total-Akt and phospho-Akt blots, cells were
serum starved overnight, and re-administered 2% fetal
bovine serum during 8 h in the presence or absence of
CdCl2 or 25 lM LY294004 (LY) before lysing. CdCl2
induces the transcription of Ep-CAM, LY294004
inhibits the Pi3K activity.
Antibodies and chemicals
The monoclonal antibodies anti-N-cadherin (clone
#32), anti-E-cadherin (clone #36), anti-a-catenin, anti-
b-catenin, and anti-p85 were obtained from Trans-
duction Laboratories (Lexington, KY). Polyclonal
antibodies against total-Akt and phospho-Akt are from
Cell Signaling Tech. (Beverly, MA). The monoclonal
antibody 323/A3, directed against Ep-CAM, was
kindly provided by Centocor B.V., the Netherlands.
Secondary antibodies for immunoblotting were labeled
with HRP (Tansduction Laboratories) and for immu-
nofluorescent stainings isotype specific antibodies were
labeled with either Alexa-488, Alexa-546 (Molecular
Probes Europe BV, Leiden, the Netherlands), or Cy-5
(PickCell, Amsterdam, the Netherlands).
For immunoprecipitations, Protein G Sepharose
beads from Amersham were labeled (Amersham Phar-
macia Biotech, Buckinhamshire, UK). At least 16 h
prior to fixation or lysis of cells, 25 lM LY294002
(Biomol Research Laboratories Inc., Plymouth Meeting,
PA) was added to the culture medium to inhibit Pi3K.
Ep-CAM expression in transfected cells was enhanced
by overnight incubation of 10 or 25 lM CdCl2.
Immunoprecipitation
Cells were grown to 80% density and overnight
induced (25 lM CdCl2). The procedure was followed
as described previously [11], using TritonX100, b-octyl
glucopyranoside, or CHAPS as detergents.
Detergent extraction, total lysates, and Western
Blot analysis
For extraction, overnight induced (25 lM CdCl2) cell
cultures were rinsed with ice-cold 1 mM CaCl2/1 mM
MgCl2 in PBS and extracted with 1% TritonX-100 or
50 mM CHAPS in extraction buffer as described previ-
ously [11]. The samples were collected and spun down
(15¢, 15,000 rpm). The detergent-insoluble fraction of
cells was separated from supernatant (the detergent-
soluble fraction), and further lysed in hot 1% SDS/
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10 mM EDTA. For total lysates, the cells were lysed in
hot lysis buffer immediately after rinsing off the culture
medium with ice-cold 1 mM CaCl2/1 mM MgCl2 in PBS.
Protein concentrations in homogeneous lysates were
measured using Bio-Rad DC Protein Assay (Bio-Rad
Lab., Hercules, CA). For all Western blots, 10 lg of
homogenous lysate was loaded per lane of the 10%
SDS-gel, representing equal protein load per lane
while avoiding control stainings [7, 8, 11]. Proteins
were separated by SDS/PAGE, and transferred elec-
trophoretically onto PVDF-membrane (Millipore,
Bedford, MA). The membrane was stained as de-
scribed previously [7]. The blots were visualized using
the ECL detection substrate (Amersham).
Pi3K activity assay
The Pi3K activity of anti-p85 immunoprecipitates was
analyzed as described previously [10].
Briefly, aliquots of cell lysates normalized for pro-
tein content were incubated with anti-Ep-CAM anti-
bodies and absorbed onto protein A-Sepharose and
washed. The reaction was carried out for 10 min in a
buffer that also contained 10 lg of PI (Avanti Polar
Lipids, Alabaster, AL) and 10 lCi [c-32P] ATP
(6,000 Ci/mmol; DuPont/NEN, Wilmington, DE).
After the incubation, the reaction was stopped with
methanol plus 2.4 N HCl (1:1, vol/vol), and lipids were
extracted, and analyzed by thin-layer chromatography.
Confocal microscopy
Cells at 80% density and overnight induced (25 lM
CdCl2) were washed with ice-cold 1 mM CaCl2/1 mM
MgCl2 in PBS, and fixed during 15 min with –20C
methanol and allowed to dry. Cells were blocked with
5% skim milk in PBS, the primary monoclonal antibody
was incubated for 1 h, followed by an hour incubation
with a fluorochrome labeled secondary antibody.
For actin staining, cells were fixed for 1 h in 4%
paraformaldehyde, permeabilized with 0.3% TritonX-
100 [11], and incubated with TRITC-labeled phalloidin
(Sigma-Aldrich Chemie Gmbh, Steinheim, Germany).
After drying, cells were mounted and examined by
confocal microscopy (Zeiss LSM 510, Jena, Germany).
Results
Pi3K switches between Ep-CAM and N-cadherin
The breast epithelial cell line HBL100 was transiently
transfected with pMep4 plasmids containing either
wt Ep-CAM cDNA, HME, or empty vector, HMC.
cDNA transcription under control of the methallo-
thionin promotor can be enhanced by incubation with
divalent cations. This enables a 3-step increase in
expression level by (1) the mock transfectant (promo-
tor only, HMC), (2) transfectant with ‘normal’ tran-
scription (HME), and (3) transfectant with enhanced
expression (HME + 25 lM CdCl2) [11]. Cell surface
expression of Ep-CAM was measured by flow cytom-
etry analysis (Fig. 1a).
Cross-signaling between E-cadherin and Ep-CAM
has previously been demonstrated to involve the con-
nection between cadherin-mediated cell–cell junctions
and F-actin [8, 11]. Cytoskeletal rearrangements are
observed upon Ep-CAM introduction in cells
expressing N-cadherin (Fig. 1b). In HME cells, the
actin cytoskeleton is concentrated in the cortical area,
in contrast to HMC cells where more fibers can be
found.
Co-immunoprecipitation for N-cadherin (Fig. 1c) or
Ep-CAM showed that the Pi3K regulatory subunit,
p85, shuttles between cadherin and Ep-CAM; most p85
is complexed with N-cadherin in HMC cells, while in
Ep-CAM expressing HME cells, the precipitation
complex with N-cadherin has ‘lost’ most of the p85
molecules. Immunoprecipitation with Ep-CAM only
precipitated molecules in the Ep-CAM expressing
HME cells, where p85 has appeared in the complex.
Interestingly, performing the immunoprecipitation for
Ep-CAM on high (95%) or low (15%) density cell
cultures, p85 and Ep-CAM only co-precipitated in
HME cells from high density cultures (Fig. 1d).
Effect of Ep-CAM on N-cadherin can be blocked
by LY
Western blotting of total lysates of HMC, HME, and
HME + CdCl2 cells showed that the amount of the
regulatory subunit of Pi3K, p85, had not changed in
these cells (Fig. 2a). Pi3K inhibitor LY294004 (LY)
incubation resulted in a slight decrease of total
N-cadherin in both HMC + CdCl2 and HME +
CdCl2. Ep-CAM expression was strongly upregulated
in HME + CdCl2 cells, but upon LY incubation the
total expression of Ep-CAM had decreased.
Immunofluorescent staining for N-cadherin and
a-catenin showed that these molecules were present at
the cell–cell boundaries in HMC, most likely in cad-
herin-mediated adhesion complexes (Fig. 2b). The
cadherin-mediated adhesion complex had turned more
diffuse in HME cells, where Ep-CAM was expressed.
Upon LY incubation, the N-cadherin and a-catenin
re-located to the cell plasma membrane, showing the
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‘spike’-like staining pattern in HME + CdCl2/LY,
while Ep-CAM had left the cell–cell boundaries.
Ep-CAM transcription and expression in cell cul-
tures (80% monolayer) were induced with 10 lM
CdCl2. Cells were subsequently incubated with 25 lM
Pi3K inhibitor LY. Cells were CHAPS detergent
extracted before lysing them, allowing discrimination
between the soluble and insoluble proteins. Figure 2c
shows the soluble fraction that represents the cadherins
and catenins that are not bound to the cytoskeleton, i.e.,
not complexed in cell–cell adherens junctions. As a
lysate, the soluble fractions of CHAPS extracted cells (i.e.,
non-bound to F-actin) were Western blotted and
stained for N-cadherin, p85, Ep-CAM, b-catenin, and a-
catenin. Per lane, 10 lg of each homogenous lysate was
loaded, representing equal protein load per lane while
avoiding control stainings. Figure 2c demonstrates that
the N-cadherin, b-catenin,and a-catenin levels had
increased upon CdCl2 enhanced Ep-CAM (Fig. 2c).
Only the soluble fraction of cadherins and catenins
increased while the total amount remained unchanged
(not shown, see [7]). The increased proteins in the sol-
uble fraction indicates that more cadherin junctional
complexes are disconnected from the cytoskeleton
upon Ep-CAM introduction, and not the result of
increased cadherin and catenin expression (the total
amount of cadherins and cadherins did not change). By
blocking Pi3K activity by LY incubation, levels of sol-
uble N-cadherin, b-catenin and a-catenin decreased,
although Ep-CAM expression levels were still high.
It is plausible that Ep-CAM, which is associated
with proliferation both in vitro and in vivo [2], reg-
ulates epithelial cell differentiation via the Pi3K/Akt
signaling pathway. To validate the active state of
Pi3K, the level of phosphorylation of Pi3K substrate,
Akt, was measured. Serum-starved HMC and HME
were Western-blotted for total-Akt and phosphory-
lated-Akt (P-Akt, Fig. 2d). Total lysates of both
HMC and HME hardly showed any P-Akt. Addition
of 2% serum had activated Pi3K, as can be
concluded from the increase in P-Akt per 10 lg in
both HMC and HME. Incubation with CdCl2, which
enhanced the expression of Ep-CAM in HME,
increased the level of P-Akt in HME, as compared
to serum-induced HME cells. This increase of Pi3K
activity could partially be blocked by LY, although
the levels of P-Akt in HME appeared to have
decreased more than in HMC. Since equal protein
concentrations were blotted and the total levels of
Akt did not change, this demonstrates Pi3K activity
as a result of Ep-CAM expression.
Pi3K is associated with Ep-CAM
Immunoprecipitations with the Pi3K regulatory
subunit, p85, using different cell lysing buffers,
Fig. 1 Expression of Ep-CAM in HbL100 cells. (a) Flow
cytometry analysis of mock (HMC) and Ep-CAM transfected
HbL100 cells (HME). The mock-transfected cells, HMC, did not
express Ep-CAM at the cell surface (white). The Ep-CAM
expression was detected in HME (gray), which was increased
upon overnight incubation with CdCl2 (black). (b) F-actin
staining of overnight CdCl2 induced HMC and HME cells, using
TRITC-conjugated phalloidin. In HME cells, the actin cytoskel-
eton is concentrated in the cortical area, in contrast to HMC
cells, where more fibers can be found. (c) 10 lg of homogenous
lysate was loaded per lane of the 10% SDS-gel, representing
equal protein load per lane. Western blotting total lysates of
HMC and HME and probed for N-cadherin, Ep-CAM and the
Pi3K subunit p85. Cell cultures were lysed after overnight
incubation with CdCl2 and LY. P85 shuttled between N-cadherin
and Ep-CAM. In HMC cells, p85 precipitated with N-cadherin.
Upon Ep-CAM introduction, HME cells, p85 now precipitated
with Ep-CAM. (d) Immunoprecipitation for Ep-CAM and p85
on high (H) or low (L) density cell cultures, and Western blotted
for Ep-CAM and p85. P85 and Ep-CAM only co-precipitated in
HME cells from high densed cultures
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demonstrated that Ep-CAM is present in the precipi-
tated complex (Fig. 3a).
It remained unclear whether this Ep-CAM/p85
complex included the Pi3K subunit p110 that employes
the kinase activity. Therefore, a kinase activity assay
was performed (Fig. 3b): The Ep-CAM/p85 complex
was precipitated with the anti-Ep-CAM antibody and
subsequently incubated with 32-P labeled ATP and PI.
If the Ep-CAM/p85 complex would have kinase
activity, this would result in the formation of PI3P,
while no PI3P was formed when precipitated with a
control antibody.
Discussion
Cross-signaling between cadherins and other adhesion
molecules is a common phenomenon [1]. Ep-CAM
expression is associated with proliferation and inhibits
epithelial differentiation [7, 9, 12]. In a previous study
we showed that the communication between Ep-CAM
and E-cadherin does not involve the regulatory mole-
cule b-catenin [8]. Ep-CAM abrogated the E-cadherin-
mediated adhesion complex by disrupting the connec-
tion between a-catenin and the actin cytoskeleton. An
identical response to Ep-CAM introduction was found
for N-cadherin [11]. Since this is not the result of a
physical interaction, one or more other molecules have
to be involved [8]. In the present study, we show that
cross-signaling between Ep-CAM and classical cadhe-
rins involves the Pi3K signaling pathway. This was al-
ready suggested by the fact that Rac/Pi3K activation
induced disassembly of cadherin-mediated adhesions.
The same findings have been described for Ep-CAM
expression [13–15]. As previously described, both
Ep-CAM and p85, the regulatory subunit of Pi3K,
are capable to bind a-actinin, although under different
conditions [11, 16]. Our results demonstrating
co-precipitation of Ep-CAM and p85 suggest for the
first time that these molecules do interact. Further-
more, our results indicate that this complex has kinase
activity. Both Ep-CAM and E-cadherin mediated-
adhesions are localized at the basal-lateral membrane
and mediate cell–cell contacts by themselves. Ep-CAM
Fig. 2 Abrogation of N-cadherin-mediated adhesions. (a) 10 lg
of homogenous lysate was loaded per lane of the 10% SDS-gel,
representing equal protein load per lane. Western blotting of
total lysates of CHAPS extracted HMC and HME cell cultures
after CdCl2 and/or LY incubation, stained for N-cadherin, Ep-
CAM and p85. In HME cells, LY incubation decreased the high
Ep-CAM expression levels. (b) Immunofluorescent staining of
HMC and HME for Ep-CAM, a-catenin and N-cadherin after
incubation with CdCl2 and LY. Ep-CAM expression in HME
cells, abrogated the presence of N-cadherin and a-catenin at the
cell–cell boundaries. In these same HME cell, inhibition of Pi3K
by LY, resulted in re-location of N-cadherin and a-catenin at the
cell–cell boundaries. (c) Western blotting of the soluble fraction
of CHAPS extracted HMC and HME cell cultures after CdCl2 and/
or LY incubation, stained for N-cadherin, Ep-CAM, Pi3K
subunit p85, b-catenin, and a-catenin. The soluble fraction
represents the cadherins and catenins that are not bound the
cytoskeleton, i.e., not complexed in cell–cell adherens junctions.
In HME cells, the soluble fraction of Ep-CAM increased upon
LY incubation, while the soluble fractions of b- and a-catenin
decreased. (d) Western blotting for total-Akt and phosphory-
lated-Akt (P-Akt) in HMC and HME total lysates after serum
starvation and subsequent addition of FBS, CdCL2, and LY. In
serum starved HMC and HME cells (first lanes of both) there
was hardly any phosphorylated Akt detectable. Addition of FBS
induced the p-Akt in HMC and HME, and upon increased
expression of Ep-CAM (Cd induced), more P-Akt was detected
in HME. This increase in P-Akt in HME was only partially
blocked by LY, although the levels of P-Akt in HME appeared
to be decreased more than in HMC
Mol Cell Biochem (2007) 302:19–26 23
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also regulates cadherin-mediated adhesions, which
might be modulated by shuttling of p85. Nelson and
Chen reported that Pi3K activity is required for cell–
cell contact induced proliferation, which is in line with
our results [17].
Pi3K activation promotes the cell entering the S
phase of the cell cycle and Pi3K activation promotes
cellular changes that are characteristic of premalignant
transformation [18]. Ep-CAM is associated with pro-
liferation both in vitro and in vivo and de novo
expression was demonstrated in adult squamous car-
cinomas [2, 3]. Akt has been shown to repress tran-
scription of the E-cadherin gene. Second, cells
expressing constitutively active Akt produce the tran-
scription factor Snail that represses the expression of
the E-cadherin gene [19]. Ep-CAM and E-cadherin
expression are reversely correlated in epithelial cells
and forced expression results in abrogation of E-
cadherin-mediated adhesions [2, 8]. Therefore, it is not
unlikely that Ep-CAM is involved in de Pi3K/Akt
signaling pathway regulating epithelial cells upon
external signals.
Signaling pathways downstream from Pi3K are
implicated in cell dissociation and scattering in MDCK
cells [20]. Furthermore, forced Ep-CAM expression in
transgenic mice induced budding and secondary
branching of the mammary glandular tree in virgin
females [21]. MAPK and Pi3K activation by Ras is
required for HGF/SF-induced adherens junction dis-
assembly in MDCK cells [14, 20], and Pi3K activity
promotes invasiveness in epithelial breast cells [22, 23].
Ep-CAM promotes invasiveness in Ep-CAM trans-
fected HBL100 cells in matrigel (our unpublished data)
and the relationship with the small GTPases in this
process is under investigation.
Both Ep-CAM and p85, the regulatory subunit of
Pi3K, can bind a-actinin, although under different
experimental conditions [11, 16]. Recently, p85 was
found to bind to a specific domain in membrane-bound
ezrin, a plasma membrane-microfilament linker.
Moreover, Gautreau and co-workers stated that sur-
vival signaling by ezrin is regulated through the Pi3K/
Akt pathway [24]. ICAM-2 clustering induced ezrin
tyrosine phosphorylation and enhanced threonine
phosphorylation, concomitant with an increase in p85/
Pi3K association in Jurkat T cells [25]. It is possible
that in the complex of Ep-CAM and Pi3K, ezrin is also
present sustaining a survival in cells that have down-
regulated E-cadherin mediated adhesion.
Potempa and Ridley found that the disassembly of
cadherin junctional complexes in migrating HGF/SF
stimulated MDCK cells could be blocked by Pi3K
inhibitors LY or PD98059 incubation as well as by
micro-injected dominant negative MAPKK1 [14].
However, activation of Pi3K or p42/p44 MAPK was
not sufficient to induce a disruption of adherens junc-
tions. Wennstro¨m and Downward reported similar
results in EGF stimulated COS-7 cells [26]. They pos-
tulated that the ability of LY to inhibit the EGF-R/
Ras/Raf/MEK pathway is due to basal Pi3K activity
that contributes to Ras activation upon weak stimuli
(e.g., low concentration of EGF) [26]. Pi3K activity
downstream from Ras can only be induced by high
concentration of EGF induced Ras or oncogenic Ras.
The basal Pi3K activity may be provided by Ep-CAM
expression.
A role for Ep-CAM as a morphoregulatory mol-
ecule becomes more plausible. Ep-CAM expression
implicates proliferation and differentiation, as previ-
ously demonstrated [3, 7, 9, 12]. Pi3K physically
interacts with activated growth receptors, transducing
survival signals. The signaling between Ep-CAM and
Pi3K has its consequences for cellular motility and/or
invasive capacity. Disturbed regulation of these
molecules may result in increased metastatic capacity,
Fig. 3 Ep-CAM and Pi3K in signaling. (a) 10 lg of homogenous
lysate was loaded per lane of the 10% SDS-gel, representing
equal protein load per lane. Immunoprecipitation with Pi3K
subunit p85 in lysates of several detergents, and blotted for p85
and Ep-CAM. OGP: b-octyl glucopyranoside. Ep-CAM is
present in the precipitated complex. (b) Kinase activity assay
for precipitates from HMC and HME. The formation of PI3P in
HME cells is the result of kinase activity in the Ep-CAM/p85
complex (lane 1; precipitate with anti Ep-CAM antibody), while
no PIP3 was formed when precipitated with a control antibody
(lane 2; anti-IgG)
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possibly by affecting the small Rho GTPases and
thereby inducing cytoskeletal rearrangements.
It can be concluded from the results described here
that Pi3K can act downstream from Ep-CAM. The
question of a potential feedback loop from Ep-CAM to
Pi3K remains to be studied. Our first experiments do
not eliminate the possibility. E.g., expression of
Ep-CAM deletion mutants incapable of adhesion,
results in altered p85 expression levels (unpublished
observations). These preliminary observations would
be in line with conclusions from other research groups.
For example, Akt, acting downstream of Pi3K, is
activated by the formation of E-cadherin-mediated
junctions [27], while formation of E-cadherin-mediated
junctions was demonstrated to be inversely correlated
to Ep-CAM expression [7]. Although the mechanism
of a putative regulation loop needs further investiga-
tion, such a mechanism may explain the observations
of both a de novo Ep-CAM expression in cervical
carcinoma [2] and the amplification of the gene
encoding for Pi3K subunit p110a in cervical and
ovarian carcinomas [28, 29].
The experiments reported here demonstrate that
Pi3K can act downstream from Ep-CAM. Abnormal
signaling between these molecules may play a crucial
role in the biology of some epithelial tumors.
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